Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

1.5K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.5K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

1.2K
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
1.2K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

42.9K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
42.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Omsk hemorrhagic fever virus: review of the biology, ecology, and disease associated with a historic tick-borne pathogen.

Infectious diseases & immunity·2026
Same author

Intranasal Immunization with Live-Attenuated RSV-Vectored SARS-CoV-2 Vaccines Elicits Antigen-Specific Systemic and Mucosal Immunity and Protects Against Viral Challenge and Natural Infection.

Vaccines·2026
Same author

Intranasal immunization with live-attenuated RSV-vectored SARS-CoV-2 vaccines elicits antigen-specific systemic and mucosal immunity and protects against viral challenge and natural infection.

bioRxiv : the preprint server for biology·2026
Same author

Aqueous Leaf Extracts of Peppermint (<i>Mentha</i> × <i>piperita</i>) and White Snakeroot (<i>Ageratina altissima</i>) Exhibit Antibacterial and Antiviral Activity.

Microorganisms·2026
Same author

Osage Orange (<i>Maclura pomifera</i>) and Spearmint (<i>Mentha spicata</i>) Leaf Extracts Exhibit Antibacterial Activity and Inhibit Human Respiratory Syncytial Virus (hRSV).

Pathogens (Basel, Switzerland)·2025
Same author

Comparative syncytia formation dynamics of coronavirus MHV-A59 and pneumovirus hRSV A2 and incorporation into improved kinetic virus replication models.

The Journal of general virology·2025

Related Experiment Video

Updated: Apr 27, 2026

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

1.6K

RNA virus reverse genetics and vaccine design.

Christopher C Stobart1, Martin L Moore2

  • 1Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA. c.c.stobart@emory.edu.

Viruses
|June 27, 2014
PubMed
Summary

Reverse genetics systems for RNA viruses enable the creation of viral mutants for developing effective vaccines and therapeutics. These systems are crucial for advancing RNA virus research and combating diseases in humans and animals.

More Related Videos

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
09:13

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on: November 1, 2011

17.1K
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

16.3K

Related Experiment Videos

Last Updated: Apr 27, 2026

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants
15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

1.6K
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
09:13

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on: November 1, 2011

17.1K
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

16.3K

Area of Science:

  • Virology
  • Molecular Biology
  • Vaccinology

Background:

  • RNA viruses pose significant public health threats due to their rapid spread and potential for severe disease.
  • The study of RNA virus genomes is essential for understanding viral pathogenesis and developing countermeasures.
  • Traditional methods for studying RNA viruses are limited in their ability to generate specific genetic modifications.

Purpose of the Study:

  • To review the impact of RNA virus reverse genetics systems on vaccine and therapeutic development.
  • To highlight the role of reverse genetics in designing and optimizing viral mutants.
  • To assess the current and future applications of these systems in combating RNA virus infections.

Main Methods:

  • Literature review of studies utilizing RNA virus reverse genetics.
  • Analysis of the application of reverse genetics in vaccine and therapeutic design.
  • Synthesis of findings on the efficacy and safety of reverse genetics-derived viral products.

Main Results:

  • Reverse genetics systems have revolutionized the study of RNA viruses.
  • These systems allow for precise manipulation of viral genomes to create attenuated or immunogenic strains.
  • Numerous successful applications in vaccine and therapeutic development have been reported.

Conclusions:

  • RNA virus reverse genetics is a powerful tool for developing novel vaccines and therapeutics.
  • Continued advancement in reverse genetics technologies will accelerate the response to emerging viral threats.
  • These systems are indispensable for the future of antiviral research and public health protection.